Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.330
-0.100 (-2.92%)
At close: Jan 17, 2025, 4:00 PM
3.360
+0.030 (0.90%)
After-hours: Jan 17, 2025, 7:48 PM EST
Kyverna Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$23.20
Upside
+596.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +80.18% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $24 | Buy | Maintains | $44 → $24 | +620.72% | Nov 15, 2024 |
| UBS | UBS | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +290.39% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +110.21% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +110.21% | Aug 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $33 | Buy | Maintains | $39 → $33 | +890.99% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $8 | Hold | Reiterates | $8 | +140.24% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $8 | Hold | Initiates | $8 | +140.24% | Jul 3, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $39 | Buy | Initiates | $39 | +1,071.17% | Mar 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +1,101.20% | Mar 4, 2024 |